发明名称 |
NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF INHIBITING ACTIVITY OF 11B-HSD1 (11B-HYDROXYSTEROID DEHYDROGENASE TYPE 1) ENZYME, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT |
摘要 |
The present invention relates to a novel compound or pharmaceutically acceptable salt thereof having the inhibiting activity of a 11β-HSD1 enzyme, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient. The compound according to the present invention selectively inhibits the activity of 11β-HSD1 (11β-Hydroxysteroid dehydrogenase type 1), thereby being practically used as a treatment for diseases casued by the overexpression of the 11β-HSD1 including non-insulin dependent type 2 diabetes, insulin tolerance, obesity, lipid disorder, and insulin resistance syndrome, and diseases and symptoms caused by the excessive action of glucocorticoid. |
申请公布号 |
KR20140050622(A) |
申请公布日期 |
2014.04.29 |
申请号 |
KR20140044028 |
申请日期 |
2014.04.14 |
申请人 |
CELLBION CO., LTD.;AHN-GOOK PHARMACEUTICAL CO., LTD.;INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
发明人 |
HAN, CHEOL KYU;AUH, JIN;CHOI, NAM SONG;HAN, CHANG KYUN;KIM, TAE JEONG;PAE, KAM SA;SHIN, YOUNG JUNE;HAN, DONG OH;AHN, SOON KIL |
分类号 |
C07C311/16;A61K31/18;A61P3/10;C07C229/48 |
主分类号 |
C07C311/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|